Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Centipede venom molecule may combat pain

Date: Oct-02-2013
A team of scientists from Australia and China has found a molecule in centipede venom that could form the basis of a new
drug to kill pain as effectively as morphine. The discovery brings new hope to millions of people whose lives are blighted because of
chronic pain.

Their findings are published in this week's online issue of the Proceedings of the National Academy of Sciences,
PNAS.

One in five people is thought to suffer from chronic pain, defined as pain that lasts for more than 6 months.

In the US, this
amounts to tens of millions of Americans, costing the economy around $600 billion per year, which is more than the annual cost of
cancer, heart disease and diabetes combined.

Chronic pain ranges in severity from mild to excruciating, from inconvenient to totally incapacitating. It can be continuous or
come and go, and pain signals can linger in the nervous system for years.

There are not many drugs available for treating chronic pain, and many that are have limited effects and cannot be taken in large
doses because of side effects.
New avenue targets NaV1.7 sodium ion channel

Some humans are born with gene mutations that make them indifferent to all types of pain. The mutated genes affect a mechanism
that the nervous system uses to conduct electrical signals - the NaV1.7 sodium ion channel.

A sodium ion channel is a highly specialized protein that acts like a chemical gateway in the membrane of the nerve cell to only
allow entry to sodium ions.

The researchers behind this new study started with the idea that there may be compounds that block the NaV1.7 sodium channel, which
could be developed into new drugs for treating pain conditions.

Professor Glenn King, senior investigator from the Institute for Molecular Bioscience at Australia's University of Queensland,
says:

"People without a functioning Nav1.7 channel cannot feel pain, so it's likely molecules that can block this channel will be
powerful painkillers."
Centipede venom blocks Nav sodium channels

The team focused their attention on centipedes because they paralyze their prey by blocking their Nav sodium channels.

They had already shown in another recent study that the venom of the Chinese red-headed centipede was rich in molecules that can
alter the function of nerve channels.

In this latest study, they identified Ssm6a, a peptide from centipede venom that potently and selectively blocks the human NaV1.7
channel.

It was important to show that the compound blocks only the NaV1.7 channel and no other, because closely related channels play key
roles in controlling the heart and muscles, says Prof. King.

He and his co-authors write how they found Ssm6a has a "150-fold selectivity for NaV1.7 over all other human NaV subtypes, with
the exception of NaV1.2, for which the selectivity is 32-fold."

Using mice, the team then showed how Ssm6a proved to have a stronger analgesic effect against pain than morphine and did not cause
any side effects.

Prof. King says:

"There are a number of FDA-approved drugs derived from venom components currently on the market, with several more in clinical
trials or various stages of preclinical development."

"Our study suggests that centipede venoms, which to date have been largely unstudied, might provide a new source of potential
drugs for treating chronic pain and other conditions."

In another remarkable study published earlier this year, researchers in the US showed how bee venom destroys HIV without harming surrounding cells.

Written by Catharine Paddock PhD

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today
Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.